Hence, the present study was designed to examine the expression of KIF18B in GBM and its clinical implications using mRNA expression data from the TCGA (Wang et al., 2016) and CGGA (Zhao et al., 2021) databases, with the goal of identifying novel therapeutic targets and advancing glioma research. Here, KIF18B is linked to glioma.